ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO0717

Fibrillary Glomerulonephritis with Focal Crescents and Concurrent c-ANCA, p-ANCA, and Myeloperoxidase (MPO) Positivity

Session Information

Category: Glomerular Diseases

  • 1402 Glomerular Diseases: Clinical, Outcomes, and Therapeutics

Authors

  • Naeem, Shanzae, Piedmont Macon Medical, Macon, Georgia, United States
  • Robinson, Nicholas, Piedmont Macon Medical, Macon, Georgia, United States
  • Sakhalkar, Om Vishwas, Piedmont Macon Medical, Macon, Georgia, United States
Introduction

Fibrillary glomerulonephritis is a rare glomerular disease characterized by Congo red–negative fibrillary deposits and now reliably identified by DNAJB9 staining. Crescentic lesions occur in a minority of cases, while ANCA positivity is rare and most commonly MPO-associated. We report a unique case of DNAJB9-positive FGN with focal crescents and triple ANCA positivity.

Case Description

A 74-year-old male with COPD, hypertension, CKD stage 3B, presented with dyspnea, and fatigue. Laboratory evaluation showed creatinine 6.76 mg/dL, BUN 62 mg/dL, nephrotic-range proteinuria (10.8 g/day), albumin 3.0 g/dL, and marked hematuria. Complements were normal. Serologies revealed c-ANCA 1:320, p-ANCA 1:320, MPO antibody 3.1, PR3 negative, ANA negative, and anti-GBM negative. SPEP/UPEP were negative. Kidney biopsy demonstrated mesangial expansion, segmental sclerosis, focal necrotizing lesions, and cellular/fibrocellular crescents nonsclerotic glomeruli with moderate interstitial fibrosis/tubular atrophy. Immunofluorescence showed smudgy mesangial/capillary loop IgG, C3. Congo red was negative. DNAJB9 staining was diffusely positive, and electron microscopy demonstrated randomly oriented nonbranching fibrils consistent with FGN. The patient received pulse methylprednisolone followed by prednisone taper and rituximab.

Discussion

This case discusses an unusual overlap of DNAJB9-confirmed FGN with crescentic/necrotizing injury and ANCA positivity. While ANCA positivity in FGN is rare, the presence of high-titer ANCA serologies together with crescents and necrosis raised concern for superimposed ANCA-mediated inflammation. Recognition of these overlapping features is important because they may influence immunosuppressive management and renal outcomes.